Jul 16, 2026 06:00PM
Jul 16, 2026 06:00PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Aug 7, 2024 06:45AM
Jun 24, 2024 03:00AM
Jun 17, 2024 06:45AM Takeda (TAK) Reports Phase 3 Topline Results for Soticlestat
Jun 17, 2024 06:45AM
May 31, 2024 09:57AM
Feb 26, 2024 11:30PM
Dec 21, 2023 04:00PM
Dec 21, 2023 04:00PM
Nov 9, 2023 03:50PM
Oct 3, 2023 04:50PM Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
Oct 2, 2023 04:35PM
Oct 2, 2023 04:30PM
Sep 25, 2023 08:45AM
Sep 25, 2023 08:44AM
May 25, 2023 04:31PM
Feb 2, 2023 05:40AM
Jan 11, 2023 08:37AM Takeda's (TAK) EXKIVITY Approved in China
Jan 11, 2023 08:36AM
Jan 5, 2023 06:46AM
Dec 19, 2022 02:30PM
Dec 8, 2022 06:45AM
Nov 22, 2022 03:57PM
Nov 22, 2022 03:57PM
Nov 11, 2022 05:25AM Takeda (TAK) Announces EC Approval of LIVTENCITYTM
Nov 11, 2022 02:00AM
Oct 14, 2022 07:30AM
Aug 22, 2022 09:58AM
Aug 22, 2022 09:57AM
Jun 9, 2022 05:10AM
Jun 9, 2022 04:30AM
Apr 22, 2022 08:04AM Takeda Pharmaceutical (TAK) Reports New Exploratory Analysis Showing Patients Treated With LIVTENCITY Had Reductions in Hospitalization Rates and Length of Hospital Stay
Apr 22, 2022 08:00AM
Dec 8, 2021 07:02AM
Dec 8, 2021 07:00AM
Dec 2, 2021 09:49AM
Nov 23, 2021 05:26PM
Nov 23, 2021 05:24PM
Oct 8, 2021 05:41AM UPDATE: FDA AdCom Unanimously Recommends Use of Takeda's (TAK) Investigational Drug Maribavir (TAK-620) to Treat Post-Transplant Recipients with Cytomegalovirus (CMV) Infection
Oct 7, 2021 06:15PM
Sep 15, 2021 04:41PM
Sep 15, 2021 04:40PM

67,416 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All